When did FIRAZYR go generic? The Timeline of Icatibant's Market Entry
•
3 min read
On July 15, 2019, the patent for the brand-name drug FIRAZYR (icatibant injection) officially expired in the United States, which paved the way for generic versions. The answer to the question, 'When did FIRAZYR go generic?' is not a single date but a series of launches that began shortly after its patent lapsed.